Significant reduction of the antistherogenic effect of estrogen by long- term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits

Journal of Clinical Investigation

Volumn 100, Issue 4, 1997, Pages 821-828

  Holm, Pernille ^a   Korsgaard, Niels ^a   Shalmi, Michael ^a   Andersen, Heidi L ^a   Hougaard, Philip ^a   Skouby, Sven O ^b   Stender, Steen ^c  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

17 estradiol; Atherosclerosis; Endothelium; Levormeloxifene; Nitric oxide

Indexed keywords

CENTCHROMAN; CHOLESTEROL; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; UNCLASSIFIED DRUG; ACETYLCHOLINE; ESTROGEN RECEPTOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA INJURY; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; RABBIT; THORACIC AORTA; ANIMAL; AORTA; ARTERIOSCLEROSIS; BALLOON DILATATION; CHEMISTRY; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; AORTA; ARTERIOSCLEROSIS; BALLOON DILATATION; CHOLESTEROL; CORONARY VESSELS; ESTRADIOL; FEMALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OVARIECTOMY; PYRROLIDINES; RABBITS; RECEPTORS, ESTROGEN;

EID: 0030610152     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119597     Document Type: Article

References (47)

1. Barret-Connor, E., and T.L. Bush. 1991. Estrogen and coronary heart disease in women. JAMA. 265:1861-1867.
2. Sullivan, J.M., R. Vander Zwaag, G.F. Lemp, J.P. Hughes, V. Maddock, F.W. Kroetz, K.B. Ramanathan, and D.M. Mirvis. 1988. Postmenopausal estrogen use and coronary atherosclerosis. Ann. Intern. Med. 108:358-363.
3. Stampfer, M.J., G.A. Colditz, W.C. Willet, J.E. Manson, B. Rosner, F.E. Seizer, and C.H. Hennekens. 1991. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses' Health Study. N. Engl. J. Med. 325:756-762.
4. Adams, M.R., J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, M.S. Wolfe, and T.B. Clarkson. 1990. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis. 10:1051-1057.
5. Haarbo, J., P. Leth-Espensen, S. Stender, and C. Christiansen. 1991. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J. Clin. Invest. 87:1274-1279.
6. Haarbo, J., O.L. Svendsen, and C. Christiansen. 1992. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ. Res. 70:1198-1202.
7. Sulistiyani, S.J. Adelman, A. Chandrasekaran, J. Rayo, and R.W. St. Clair. 1995. Effect of 17α-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 15:837-846.
8. Kushwaha, R.S., and W.R. Hazzard. 1981. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 30:359-366.
9. Walsh, B.W., I. Shiff, B. Rosner, L. Breenberg, V. Ravnikar, and F.M. Sacks. 1991. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325:1196-1204.
10. Bush, T.L., E. Barret-Connor, L.D. Cowan, M.H. Criqui, R.B. Wallace, C.M. Suchindran, H.A. Tyroler, and B.M. Rifkind. 1987. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1102-1109.
11. Williams, J.K., M.R. Adams, D.M. Herrington, and T.B. Clarkson. 1992. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 20:452-457.
12. Williams, J.K., M.R. Adams, and H.S. Klopfenstein. 1990. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1680-1687.
13. Reis, S.E., S.T. Gloth, R.S. Blumenthal, J.R. Resar, H.A. Zacur, G. Gerstenblith, and J.A. Brinker. 1994. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:52-60.
14. Gilligan, D.M., A.A. Quyyumi, and R.O. Cannon III. 1994. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:2545-2551.
15. Collins, P., G.M.C. Rosano, P.M. Sarrel, L. Ulrich, S. Adamopoulos, C.M. Beale, J.G. McNeill, and P.A. Poole-Wilson. 1995. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:24-30.
16. Hishikawa, K., T. Nakaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta. 1995. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:291-293.
17. Hayashi, T., K. Yamada, T. Esaki, M. Kuzuya, S. Satake, T. Ishikawa, H. Hidaka, and A. Iguchi. 1995. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem. Biophys. Res. Commun. 214:847-855.
18. Weiner, C.P., I. Lizasoain, S.A. Baylis, R.G. Knowles, I.G. Charles, and S. Moncada. 1994. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA. 91:5212-5216.
19. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
20. Cooke, J.P., and P. Tsao. 1992. Cellular mechanisms of atherogenesis and the effects of nitric oxide. Curr. Opin. Cardiol. 7:799-804.
21. Hayashi, T., J.M. Fukuto, L.J. Ignarro, and G. Chaudhuri. 1992. Basal release of nitric oxide from aortic rings is greater in female than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. USA. 89:11259-11263.
22. Holm, P., H.Ø. Andersen, B.G. Nordestgaard, B.F. Hansen, K. Kjeldsen, and S. Stender. 1995. Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas. Atherosclerosis. 115:191-200.
23. Holm, P., S. Stender, H.Ø. Andersen, B.F. Hansen, and B.G. Nordestgaard. 1997. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler. Thromb. Vasc. Biol. In press.
24. Martin, W., G.M., Villani, D. Jothianandan, and R.F. Furchgott. 1985. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. PharmacoL Exp. Ther. 232:708-716.
25. Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
26. De Mey, J.G., and D.L. Brutsaert. 1984. Mechanical properties of resting and active isolated coronary arteries. Circ. Res. 55:1-9.
27. Altman, D.G. 1991. Practical Statistics for Medical Research. Chapman and Hall, London. 611 pp.
28. Busse, R., A. Mülsch, I. Fleming, and M. Hecker. 1993. Mechanisms of nitric oxide release from the vascular endothelium. Circulation. 87(Suppl. V): 18-25.
29. Gislard, V., V.M. Miller, and P.M. Vanhoutte. 1988. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244:19-22.
30. Moncada, S., D.D. Rees, R. Shulz, and M.J. Palmer. 1991. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA. 88: 2166-2170.
31. Naruse, K., K. Shimizu, M. Muramatsu, Y. Toki, Y. Miyazaki, K. Okumura, H. Hashimoto, and T. Ito. 1994. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler. Thromb. 14:746-752.
32. G-nitro-L-arginine methyl esler in conscious Brattleboro rats. Br. J. Pharmacol. 101:10-12.
33. Baylis, C., B. Mitruka, and A. Deng. 1992. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90:278-281.
34. Ward, J.E., and J.A. Angus. 1993. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J. Cardiovasc. Pharmacol. 21:804-814.
35. Cayatte, A.J., J.J. Palacino, K. Horten, and R.A. Cohen. 1994. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14:753-759.
36. Candipan, R.C., B. Wang, R. Buitrago, P.S. Tsao, and J.P. Cooke. 1996. Regression or progression. Dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol. 16:44-50.
37. Fischer-Dzoga, K., R.W. Wissler, and D. Vesselinovitch. 1983. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp. Mol. Pathol. 39:355-363.
38. Nathan, L., S. Pervin, R. Singh, J. Ricks, and M. Rosenfeld. 1996. Estradiol reduces monocyte adherence to vascular endothelium in vivo. Circulation. 94:1-151. (Abstr.)
39. Frazier-Jessen, M.R., and E.J. Kovacs. 1995. Estrogen modulation of JE/monocyte chemoattractant protein-1 expression in murine macrophages. J. Immunol. 154:1838-1845.
40. Sack, M.N., D.J. Rader, and R.O. Cannon III. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:269-270.
41. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1987. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin in platelets. Br. J. Pharmacol. 92:181-187.
42. Stamler, J.S., M.E. Mendelsohn, P. Amarante, D. Smick, N. Andon, P.P. Davies, J.P. Cooke, and J. Loscalzo. 1989. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65:789-795.
43. Garg, U.C., and A. Hassid. 1989. Nitric-oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
44. Tsao, P.S., L.M. McEvoy, H. Drexler, E.C. Butcher, and J.P. Cooke. 1994. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 89:2176-2182.
45. Niu, X., C.W. Smith, and P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:113-114.
46. Marui, N., N.K. Offerman, R. Swerlick, C. Kunsch, C.A. Rosen, M. Ahmad, R.W. Alexander, and R.M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866-1874.
47. Peng, H.B., P. Libby, and J.K. Liao. 1995. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:14214-14219.